Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Would also be good to have a reminder option for injection days or days where the next pen needs to be ordered
Our comprehensive approach to weight management combines expert medical guidance, personalized care, and cutting-edge treatments like GLP-1 medications to support your journey toward better health
Side-by-side compound comparison Receptor targets Tirzepatide GLP-1 + GIP (dual) Semaglutide GLP-1 only Retatrutide GLP-1 + GIP + Glucagon (triple) Half-life Tirzepatide ~5 days Semaglutide ~7 days Retatrutide ~6 days Dosing frequency Tirzepatide Once weekly Semaglutide Once weekly Retatrutide Once weekly Max studied dose Tirzepatide 15 mg / week Semaglutide 2.4 mg / week (Wegovy) Retatrutide 12 mg / week Peak weight loss Tirzepatide 22.5% (SURMOUNT-1, 72 wk) Semaglutide 15.8% (STEP-1, 68 wk) Retatrutide 24.2% (Phase 2, 48 wk) FDA status (June 2026) Tirzepatide Approved (T2D, obesity, OSA) Semaglutide Approved (T2D, obesity, CV risk) Retatrutide Investigational Phase 3 Head-to-head Tirzepatide 20.2% vs semaglutide 13.7% (SURMOUNT-5) Semaglutide Retatrutide Not yet head-to-head vs tirzepatide HFpEF benefit Tirzepatide Yes (SUMMIT, HR 0.62) Semaglutide Yes (STEP-HFpEF) Retatrutide Not yet studied Unique advantage Tirzepatide Best-in-class FDA-approved efficacy
Retatrutide dosage for special populations Retatrutide dosage may vary for the elderly, patients with chronic kidney disease, liver and kidney failure, diabetes, cardiovascular disease, and other health conditions
Which Copper Peptide Option Is Better for Skin Aging
While it can survive at room temperature for several weeks without significant degradationwhich is perfectly fine for shippinglong-term stability is best achieved under refrigeration
US$ 27.85
US$ 22.10
US$ 22.17
US$ 20.10
US$ 28.26
